PBM

Psyence Biomedical Ltd. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website -
Employees(FY) -
ISIN CA74449F1009

Performance

+17.86%

1W

+7.61%

1M

-9.4%

3M

-90.6%

6M

-88.53%

YTD

-90.11%

1Y

Profile

-

Advanced Technical Analysis

Technical Analysis of PBM 2024-05-03

Overview:

In analyzing the technical indicators for PBM stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potentia...

Recent News & Updates

2024-04-16 20:00
Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)(Globenewswire)
2024-04-15 23:01
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENu CRO to Train Research Therapists for Phase IIb Psilocybin Trial(Globenewswire)
2024-04-15 23:01
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGEN CRO to Train Research Therapists for Phase IIb Psilocybin Trial(Globenewswire)
2024-04-07 20:00
Psyence Biomed Partners with Fluence and iNGEN CRO to Train Research Therapists for Phase IIb Psilocybin Trial(Globenewswire)
2024-04-07 20:00
Psyence Biomed Partners with Fluence and iNGENu CRO to Train Research Therapists for Phase IIb Psilocybin Trial(Globenewswire)
2024-04-07 20:00
Fluence Partners with Psyence Biomed and iNGEN CRO to Train Research Therapists for Phase IIb Psilocybin Trial(Prweb)
2024-03-25 23:06
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business(Globenewswire)
2024-03-18 04:05
Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin(Globenewswire)
2024-03-15 04:30
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares(Globenewswire)
2024-03-11 23:15
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study(Globenewswire)
2024-03-11 19:00
Psyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future Milestones(Globenewswire)
2024-03-10 19:00
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division(Globenewswire)
2024-03-08 02:59
Why Is Psyence Biomedical (PBM) Stock Up 90% Today?(Investorplace)
2024-03-05 18:00
Psyence Biomedical's Subsidiary, Psyence Australia, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study(Globenewswire)

Page 1 of 1

previousnext

Home

Market Lens

Ideas Explorer

History

Recent Activity

PBM

Performance

Profile

Technical Analysis of PBM 2024-05-03

Overview:

Recent News & Updates